Merk reported $3.44B in Cost of Sales for its third fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Abbott ABT:US $ 4493M 530M
Abbvie ABBV:US $ 4361M 689M
Amgen AMGN:US $ 1597M 36M
AstraZeneca AZN:LN 1515M 125M
Astrazeneca AZN:US 1.52B 125M
Biogen BIIB:US $ 490.6M 41.5M
Bristol Myers Squibb BMY:US $ 2302M 197M
Catalent CTLT:US $ 612.6M 15.8M
Eli Lilly And LLY:US $ 1719.8M 393.4M
Gilead Sciences GILD:US $ 1398M 257M
GlaxoSmithKline GSK:LN 2962M 244M
Glaxosmithkline GSK:US $ 2962M 244M
Johnson & Johnson JNJ:US $ 7814M 874M
Medtronic MDT:US $ 2621M 52M
Novartis NVS:US $ 3940M 372M
Perrigo Ordinary Shares PRGO:US $ 785.6M 1.2M
Pfizer PFE:US $ 2887M 390M
Phibro Animal Health PAHC:US $ 137.88M 6.81M
Prestige Brands PBH:US $ 99.9M 0.14M
Regeneron Pharmaceuticals REGN:US $ 353.1M 79.1M
Revance Therapeutics RVNC:US $ 3.66M 2.58M
Zoetis ZTS:US $ 598M 55M